Drug Type TCR therapy |
Synonyms |
Target |
Mechanism KRAS modulators(GTPase KRas modulators) |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Pancreatic Adenocarcinoma | Phase 1 | CN | 01 Jul 2024 | |
Colorectal Cancer | Phase 1 | CN | 01 Jul 2024 | |
KRAS Mutant Pancreatic Cancer | IND Approval | CN | 09 Oct 2024 |